VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $155 | -11.9% | 25,990 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $176 | -8.3% | 25,990 | 0.0% | 0.01% | -17.6% |
| Q4 2022 | $192 | -99.8% | 25,990 | +138.7% | 0.02% | +70.0% |
| Q3 2022 | $108,000 | -9.2% | 10,890 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $119,000 | -3.3% | 10,890 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $123,000 | -28.1% | 10,890 | 0.0% | 0.01% | -30.8% |
| Q4 2021 | $171,000 | -8.6% | 10,890 | 0.0% | 0.01% | -13.3% |
| Q3 2021 | $187,000 | -20.1% | 10,890 | 0.0% | 0.02% | -21.1% |
| Q2 2021 | $234,000 | +42.7% | 10,890 | 0.0% | 0.02% | +26.7% |
| Q1 2021 | $164,000 | +14.7% | 10,890 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $143,000 | +36.2% | 10,890 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $105,000 | -18.0% | 10,890 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $128,000 | +13.3% | 10,890 | 0.0% | 0.02% | -6.2% |
| Q1 2020 | $113,000 | – | 10,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |